Cart
sales@molnova.com
Apigenin-5-O-β-D-primeveroside
CAS No. 2382681-38-9
Apigenin-5-O-β-D-primeveroside( ——— )
Catalog No. M38395 CAS No. 2382681-38-9
5-O-Primeverosylapigenin is a primeverosylapigenin, which can be isolated from Gentianaceae species.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameApigenin-5-O-β-D-primeveroside
-
NoteResearch use only, not for human use.
-
Brief Description5-O-Primeverosylapigenin is a primeverosylapigenin, which can be isolated from Gentianaceae species.
-
Description5-O-Primeverosylapigenin is a primeverosylapigenin, which can be isolated from Gentianaceae species.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number2382681-38-9
-
Formula Weight564.49
-
Molecular FormulaC26H28O14
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Feng CY, et al. Determination of xanthones and flavonoids of methanol extracts obtained from different parts of the plants of three Gentianaceae species. J Pharm Biomed Anal. 2018 Nov 30;161:455-463. ?
molnova catalog
related products
-
T-900607
T-900607 is a novel microtubule protein active agent that disrupts microtubule polymerization through a unique mechanism of action. t-900607 is cardiotoxic.
-
IGF-I 30-41
IGF-I (30-41) is amino acids 30 to 41 fragment of Insulin-like Growth Factor I (IGF-I).
-
NNMTi
NNMTi? is a substrate site-targeting, selective nicotinamide N-methyltransferase (NNMT) inhibitor (IC50 = 1.2 μM;?50 μM SAM, 100 μM NCA) that reduces 3T3-L1 lipogenesis (EC50 = 30μM) and adipocytes 1-methylnicotinamide level (EC50 = 2.3 μM) without affecting related methyltransferases & enzymes in the NAD+ salvage pathwayNNMTi treatment will rescue age-related deficits in muSC activity to promote superior regeneration post-injury in aging muscle.
